Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19

Fung, 2019, Human coronavirus: host-pathogen interaction, Annu Rev Microbiol., 73, 529, 10.1146/annurev-micro-020518-115759

Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia, N Engl J Med., 382, 1199, 10.1056/nejmoa2001316

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585

2020, Global Economic Prospects, June 2020

Gibson, 2020, COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS, Med J Aust, 213, 54, 10.5694/mja2.50674

Krammer, 2020, SARS-CoV-2 vaccines in development, Nature., 586, 516, 10.1038/s41586-020-2798-3

Kandimalla, 2020, Current status of multiple drug molecules, and vaccines: an update in SARS-CoV-2 therapeutics, Mol Neurobiol., 57, 4106, 10.1007/s12035-020-02022-0

Sanders, 2020, Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review, JAMA J Am Med Assoc., 323, 1824, 10.1001/jama.2020.6019

Han, 2021, Identification of SARS-CoV-2 inhibitors using lung and colonic organoids, Nature, 589, 270, 10.1038/s41586-020-2901-9

Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052

Holwerda, 2020, Identification of an antiviral compound from the pandemic response box that efficiently inhibits sars-cov-2 infection in vitro, Microorganisms., 8, 1, 10.3390/microorganisms8121872

Mulay, 2021, SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery, Cell Rep., 109055, 10.1016/j.celrep.2021.109055

Pizzorno, 2020, Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia, Cell Rep Med., 1, 100059, 10.1016/j.xcrm.2020.100059

Suzuki, 2020, Generation of human bronchial organoids for SARS-CoV-2 research, bioRxiv [Preprint]., 10.1101/2020.05.25.115600

George, 2020, Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy, Lancet Respir. Med., 8, 807, 10.1016/S2213-2600(20)30225-3

Guler, 2021, Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study, Eur Respir J., 2003690, 10.1183/13993003.03690-2020

Kotton, 2014, Lung regeneration: mechanisms, applications and emerging stem cell populations, Nat Med., 20, 822, 10.1038/nm.3642

Schneider, 2019, On the topological complexity of human alveolar epithelial type 1 cells, Am J Respir Crit Care Med., 199, 1153, 10.1164/rccm.201810-1866LE

Weibel, 2015, On the tricks alveolar epithelial cells play to make a good lung, Am J Respir Crit Care Med., 191, 504, 10.1164/rccm.201409-1663OE

Cañadas, 2020, Lipid-protein protein-protein interactions in the pulmonary surfactant system their role in lung homeostasis, Int J Mol Sci., 21, 3708, 10.3390/ijms21103708

Olajuyin, 2019, Alveolar type 2 progenitor cells for lung injury repair, Cell Death Discov., 5, 63, 10.1038/s41420-019-0147-9

Mason, 1977, Type II alveolar cell. Defender of the alveolus, Am Rev Respir Dis., 115, 81, 10.1164/arrd.1977.115.S.81

Beers, 2017, When is an alveolar type 2 cell an alveolar type 2 cell? A conundrum for lung stem cell biology and regenerative medicine, Am J Respir Cell Mol Biol., 57, 18, 10.1165/rcmb.2016-0426PS

Barkauskas, 2013, Type 2 alveolar cells are stem cells in adult lung, J Clin Invest., 123, 3025, 10.1172/JCI68782

Zacharias, 2018, Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor, Nature., 555, 251, 10.1038/nature25786

Jain, 2015, Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung, Nat Commun., 6, 6727, 10.1038/ncomms7727

de Mello Costa, 2020, Basal-like progenitor cells: a review of dysplastic alveolar regeneration and remodeling in lung repair, Stem Cell Reports., 15, 1015, 10.1016/j.stemcr.2020.09.006

Wang, 2020, EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma, Am J Physiol Lung Cell Mol Physiol, 319, L794, 10.1152/AJPLUNG.00279.2019

Hegab, 2015, Mimicking the niche of lung epithelial stem cells and characterization of several effectors of their in vitro behavior, Stem Cell Res., 15, 109, 10.1016/j.scr.2015.05.005

Nabhan, 2018, Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells, Science., 359, 1118, 10.1126/science.aam6603

Klingberg, 2013, The myofibroblast matrix: implications for tissue repair and fibrosis, J Pathol., 229, 298, 10.1002/path.4104

Crosby, 2010, Epithelial repair mechanisms in the lung, Am J Physiol Lung Cell Mol Physiol., 298, L715, 10.1152/ajplung.00361.2009

Wynn, 2016, Macrophages in tissue repair, regeneration, and fibrosis, Immunity., 44, 450, 10.1016/j.immuni.2016.02.015

Raslan, 2020, WNT signaling in lung repair and regeneration, Mol Cells., 43, 774, 10.14348/molcells.2020.0059

Sisson, 2010, Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis, Am J Respir Crit Care Med., 181, 254, 10.1164/rccm.200810-1615OC

Piñeiro-Hermida, 2020, Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging, J Cell Biol., 219, 1, 10.1083/jcb.202002120

Waters, 2012, Mechanobiology in lung epithelial cells: measurements, perturbations, and responses, Compr Physiol., 2, 1, 10.1002/cphy.c100090

Ashino, 2000, [Ca(2+)](i) oscillations regulate type II cell exocytosis in the pulmonary alveolus, Am J Physiol Lung Cell Mol Physiol., 279, L5, 10.1152/ajplung.2000.279.1.L5

Dietl, 2001, Mechanisms of surfactant exocytosis in alveolar type II cells in vitro and in vivo, News Physiol Sci, 16, 239, 10.1152/physiologyonline.2001.16.5.239

Edwards, 2001, Stretch stimulation: its effects on alveolar type II cell function in the lung, Comp Biochem Physiol A Mol Integr Physiol., 129, 245, 10.1016/s1095-6433(01)00321-x

Gil, 1979, Alveolar volume-surface area relation in air- and saline-filled lungs fixed by vascular perfusion, J Appl Physiol., 47, 990, 10.1152/jappl.1979.47.5.990

Mercer, 1987, Three-dimensional reconstruction of alveoli in the rat lung for pressure-volume relationships, J Appl Physiol., 62, 1480, 10.1152/jappl.1987.62.4.1480

Tschumperlin, 1999, Alveolar epithelial surface area-volume relationship in isolated rat lungs, J Appl Physiol., 86, 2026, 10.1152/jappl.1999.86.6.2026

Knudsen, 2018, The micromechanics of lung alveoli: structure and function of surfactant and tissue components, Histochem Cell Biol., 150, 661, 10.1007/s00418-018-1747-9

Fredberg, 2006, Stress transmission in the lung: pathways from organ to molecule, Annu Rev Physiol., 68, 507, 10.1146/annurev.physiol.68.072304.114110

Desai, 2008, Mechanical stretch decreases migration of alveolar epithelial cells through mechanisms involving Rac1 and Tiam1, Am J Physiol Lung Cell Mol Physiol., 295, L958, 10.1152/ajplung.90218.2008

Crosby, 2011, Balance of life and death in alveolar epithelial type II cells: proliferation, apoptosis, and the effects of cyclic stretch on wound healing, Am J Physiol Lung Cell Mol Physiol., 301, L536, 10.1152/ajplung.00371.2010

Ito, 2014, Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling, Am J Physiol Lung Cell Mol Physiol., 307, L94, 10.1152/ajplung.00233.2013

Felder, 2019, Impaired wound healing of alveolar lung epithelial cells in a breathing lung-on-a-chip, Front Bioeng Biotechnol., 7, 3, 10.3389/fbioe.2019.00003

van Riet, 2020, In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells, Sci Rep., 10, 5499, 10.1038/s41598-020-62226-1

Oeckler, 2007, Ventilator-associated lung injury: a search for better therapeutic targets, Eur Respir J, 30, 1216, 10.1183/09031936.00104907

Rocco, 2020, What have we learned from animal models of ventilator-induced lung injury?, Intensive Care Med., 46, 2377, 10.1007/s00134-020-06143-x

Sehlmeyer, 2020, Alveolar dynamics and beyond - the importance of surfactant protein c and cholesterol in lung homeostasis and fibrosis, Front Physiol., 11, 386, 10.3389/fphys.2020.00386

Lentz, 2020, Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS, Am J Emerg Med., 38, 2194, 10.1016/j.ajem.2020.06.082

Ravasio, 2011, Interfacial sensing by alveolar type II cells: a new concept in lung physiology?, Am J Physiol Physiol., 300, C1456, 10.1152/ajpcell.00427.2010

Hobi, 2012, Interfacial stress affects rat alveolar type II cell signaling and gene expression, Am J Physiol Cell Mol Physiol., 303, L117, 10.1152/ajplung.00340.2011

Doyle, 2000, Composition of alveolar surfactant changes with training in humans, Respirology., 5, 211, 10.1046/j.1440-1843.2000.00251.x

Orgeig, 2015, Evolution, development, and function of the pulmonary surfactant system in normal and perturbed environments, Compr Physiol., 6, 363, 10.1002/cphy.c150003

Pastrana-Rios, 1994, A direct test of the “squeeze-out” hypothesis of lung surfactant function. External reflection FT-IR at the air/wave interface, Biochemistry., 33, 5121, 10.1021/bi00183a016

Nag, 1999, SP-B refining of pulmonary surfactant phospholipid films, Am J Physiol Cell Mol Physiol., 277, L1179, 10.1152/ajplung.1999.277.6.L1179

Hobi, 2016, A small key unlocks a heavy door: the essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies, Biochim Biophys Acta Mol Cell Res., 1863, 2124, 10.1016/j.bbamcr.2016.04.028

Roldan, 2016, Effect of lung surfactant protein SP-C and SP-C-promoted membrane fragmentation on cholesterol dynamics, Biophys J, 111, 1703, 10.1016/j.bpj.2016.09.016

Roldan, 2017, Divide andamp; conquer: surfactant protein SP-C and cholesterol modulate phase segregation in lung surfactant, Biophys J, 113, 847, 10.1016/j.bpj.2017.06.059

Günther, 1999, Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis, Eur Respir J, 14, 565, 10.1034/j.1399-3003.1999.14c14.x

Schmidt, 2001, Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia, Am J Respir Crit Care Med., 163, 95, 10.1164/ajrccm.163.1.9903029

Hobi, 2014, Physiological variables affecting surface film formation by native lamellar body-like pulmonary surfactant particles, Biochim Biophys Acta Biomembr., 1838, 1842, 10.1016/j.bbamem.2014.02.015

Li, 2016, Structure, function, and evolution of coronavirus spike proteins, Annu Rev Virol., 3, 237, 10.1146/annurev-virology-110615-042301

Ou, 2020, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat Commun., 11, 1620, 10.1038/s41467-020-15562-9

Shang, 2020, Cell entry mechanisms of SARS-CoV-2, Proc Natl Acad Sci USA., 117, 11727, 10.1073/pnas.2003138117

Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell., 181, 281, 10.1016/j.cell.2020.02.058

Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science., 367, 1260, 10.1126/science.abb2507

Letko, 2020, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat Microbiol., 5, 562, 10.1038/s41564-020-0688-y

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature., 579, 270, 10.1038/s41586-020-2012-7

Millet, 2015, Host cell proteases: critical determinants of coronavirus tropism and pathogenesis, Virus Res., 202, 120, 10.1016/j.virusres.2014.11.021

Simmons, 2005, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci USA, 102, 11876, 10.1073/pnas.0505577102

Matsuyama, 2010, Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J Virol., 84, 12658, 10.1128/JVI.01542-10

Glowacka, 2011, Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol., 85, 4122, 10.1128/JVI.02232-10

Shulla, 2011, A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry, J Virol., 85, 873, 10.1128/JVI.02062-10

Shirato, 2013, Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2, J Virol., 87, 12552, 10.1128/JVI.01890-13

Millet, 2014, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein, Proc. Natl. Acad. Sci. USA, 111, 15214, 10.1073/pnas.1407087111

Hou, 2020, SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract, Cell., 182, 429, 10.1016/j.cell.2020.05.042

Sungnak, 2020, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat Med., 26, 681, 10.1038/s41591-020-0868-6

Zou, 2020, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front Med., 14, 185, 10.1007/s11684-020-0754-0

Muus, 2021, Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics, Nat Med., 27, 546, 10.1038/s41591-020-01227-z

Pan, 2020, Viral load of SARS-CoV-2 in clinical samples, Lancet Infect Dis., 20, 411, 10.1016/S1473-3099(20)30113-4

Wang, 2020, Detection of SARS-CoV-2 in different types of clinical specimens, JAMA, 323, 1843, 10.1001/jama.2020.3786

Zhang, 2020, Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerg Microbes Infect, 9, 386, 10.1080/22221751.2020.1729071

Martines, 2020, Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States, Emerg Infect Dis., 26, 2005, 10.3201/eid2609.202095

Wölfel, 2020, Virological assessment of hospitalized patients with COVID-2019, Nature., 581, 465, 10.1038/s41586-020-2196-x

Zeng, 2020, Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion, Histopathology., 77, 823, 10.1111/his.14138

Lukassen, 2020, SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J., 39, e105114, 10.15252/embj.20105114

Lamers, 2020, SARS-CoV-2 productively infects human gut enterocytes, Science., 369, 50, 10.1126/science.abc1669

Ravindra, 2020, Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium, bioRxiv., 1, 10.1101/2020.05.06.081695

Salahudeen, 2020, Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures, bioRxiv., 10.1101/2020.07.27.212076

Ziegler, 2020, SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues, Cell., 181, 1016, 10.1016/j.cell.2020.04.035

Blanco-Melo, 2020, Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19, Cell., 181, 1036, 10.1016/j.cell.2020.04.026

Bussani, 2020, Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology, EBioMedicine., 61, 103104, 10.1016/j.ebiom.2020.103104

Thacker, 2020, Rapid endothelialitis and vascular inflammation characterise SARS-CoV-2 infection in a human lung-on-chip model, bioRxiv [Preprint], 10.1101/2020.08.10.243220

Tindle, 2020, Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19, bioRxiv Prepr. Serv. Biol., 10.1101/2020.10.17.344002

Youk, 2020, Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2, Cell Stem Cell., 27, 905, 10.1016/j.stem.2020.10.004

Huang, 2020, SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response, Cell Stem Cell, 27, 962, 10.1016/j.stem.2020.09.013

Katsura, 2020, Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction, Cell Stem Cell., 27, 890, 10.1016/j.stem.2020.10.005

Andersen, 2020, The proximal origin of SARS-CoV-2, Nat. Med., 26, 450, 10.1038/s41591-020-0820-9

Hoffmann, 2020, A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells, Mol Cell, 78, 779, 10.1016/j.molcel.2020.04.022

Daly, 2020, Neuropilin-1 is a host factor for SARS-CoV-2 infection, Science., 370, 861, 10.1126/science.abd3072

Lau, 2020, Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction, Emerg Microbes Infect., 9, 837, 10.1080/22221751.2020.1756700

Ackermann, 2020, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19, N Engl J Med., 383, 120, 10.1056/NEJMoa2015432

V'kovski, 2020, Coronavirus biology and replication: implications for SARS-CoV-2, Nat Rev Microbiol., 19, 155, 10.1038/s41579-020-00468-6

Adorni, 2020, Self-Reported symptoms of SARS-CoV-2 infection in a nonhospitalized population in italy: cross-sectional study of the EPICOVID19 web-based survey, JMIR Public Heal Surveill., 6, e21866, 10.2196/21866

Bergquist, 2020, Non-hospitalized adults with COVID-19 differ noticeably from hospitalized adults in their demographic, clinical, social characteristics, SN Compr Clin Med., 2, 1, 10.1007/s42399-020-00453-3

Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6

Oran, 2020, Prevalence of asymptomatic SARS-CoV-2 infection : a narrative review, Ann Intern Med., 173, 362, 10.7326/M20-3012

Inui, 2020, Chest CT findings in cases from the cruise ship diamond princess with coronavirus disease (COVID-19), Radiol Cardiothorac Imaging., 2, e200110, 10.1148/ryct.2020200110

Tian, 2020, Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer, J Thorac Oncol, 15, 700, 10.1016/j.jtho.2020.02.010

Lan, 2020, Positive RT-PCR test results in patients recovered from COVID-19, JAMA., 323, 1502, 10.1001/jama.2020.2783

Rogliani, 2020, Are there pulmonary sequelae in patients recovering from COVID-19?, Respir Res., 21, 286, 10.1186/s12931-020-01550-6

Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest., 130, 2620, 10.1172/JCI137244

Rodriguez-Morales, 2020, Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis, Travel Med Infect Dis., 34, 101623, 10.1016/j.tmaid.2020.101623

Tian, 2020, Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies, Mod Pathol, 33, 1007, 10.1038/s41379-020-0536-x

Zhang, 2020, Viral and host factors related to the clinical outcome of COVID-19, Nature, 583, 437, 10.1038/s41586-020-2355-0

Severe, 2020, Genomewide association study of severe covid-19 with respiratory failure, N Engl J Med., 383, 1522, 10.1056/NEJMoa2020283

Zietz, 2020, Associations between blood type and COVID-19 infection, intubation, and death, Nat Commun., 11, 5761, 10.1038/s41467-020-19623-x

Yao, 2020, D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study, J Intensive Care., 8, 49, 10.1186/s40560-020-00466-z

Menter, 2020, Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction, Histopathology., 77, 198, 10.1111/his.14134

Gupta, 2020, Extrapulmonary manifestations of COVID-19, Nat Med., 26, 1017, 10.1038/s41591-020-0968-3

Sorci, 2020, Explaining among-country variation in COVID-19 case fatality rate, Sci Rep., 10, 18909, 10.1038/s41598-020-75848-2

Wang, 2020, Analysis of the clinical characteristics of 77 COVID-19 deaths, Sci Rep, 10, 16384, 10.1038/s41598-020-73136-7

Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med., 8, 420, 10.1016/S2213-2600(20)30076-X

Bauer, 2006, Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data, Clin Infect Dis., 43, 748, 10.1086/506430

Cardinal-Fernández, 2017, Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship, Ann Am Thorac Soc., 14, 844, 10.1513/AnnalsATS.201609-728PS

Nienhold, 2020, Two distinct immunopathological profiles in autopsy lungs of COVID-19, Nat Commun., 11, 5086, 10.1038/s41467-020-18854-2

Horwitz, 2020, Trends in COVID-19 risk-adjusted mortality rates, J Hosp Med., 16, 90, 10.12788/jhm.3552

Herridge, 2011, Functional disability 5 years after acute respiratory distress syndrome, N Engl J Med., 364, 1293, 10.1056/NEJMoa1011802

Nöbauer-Huhmann, 2001, Changes in lung parenchyma after acute respiratory distress syndrome (ARDS): assessment with high-resolution computed tomography, Eur Radiol., 11, 2436, 10.1007/s003300101103

Yang, 2003, Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection, Infect. Immun., 71, 614, 10.1128/iai.71.2.614-620.2003

Drakopanagiotakis, 2008, Apoptosis in lung injury and fibrosis, Eur Respir J, 32, 1631, 10.1183/09031936.00176807

Kligerman, 2013, From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia, Radiographics., 33, 1951, 10.1148/rg.337130057

Venosa, 2020, Modeling immune effector responses in alveolar epithelial cell driven lung injury and fibrosis, J Immunol, 204, 74.1, 10.4049/jimmunol.204.Supp.74.14

Yanagi, 2015, Breakdown of epithelial barrier integrity and overdrive activation of alveolar epithelial cells in the pathogenesis of acute respiratory distress syndrome and lung fibrosis, Biomed Res Int., 2015, 573210, 10.1155/2015/573210

Glasser, 2016, Mechanisms of lung fibrosis resolution, Am J Pathol., 186, 1066, 10.1016/j.ajpath.2016.01.018

Naikawadi, 2016, Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis, JCI Insight., 1, e86704, 10.1172/jci.insight.86704

Hancock, 2018, Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice, Nat Commun., 9, 5363, 10.1038/s41467-018-07768-9

Venosa, 2019, Epithelial expression of an interstitial lung disease-associated mutation in surfactant protein-c modulates recruitment and activation of key myeloid cell populations in mice, J Immunol., 202, 2760, 10.4049/jimmunol.1900039

Bilgili, 2019, Telomere abnormalities in the pathobiology of idiopathic pulmonary fibrosis, J Clin Med., 8, 1232, 10.3390/jcm8081232

Yin, 2014, Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia, Respir Res., 15, 116, 10.1186/s12931-014-0116-z

Kasper, 2017, Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis, Biosci Rep., 37, 1, 10.1042/BSR20171301

Agostini, 2006, Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis, Proc Am Thorac Soc., 3, 357, 10.1513/pats.200601-010TK

Chambers, 2015, Mechanisms of alveolar epithelial injury, repair, and fibrosis, Ann Thorac Soc, 1, S16, 10.1513/AnnalsATS.201410-448MG

Fujiwara, 2017, Inhibition of cell apoptosis and amelioration of pulmonary fibrosis by thrombomodulin, Am J Pathol., 187, 2312, 10.1016/j.ajpath.2017.06.013

Kim, 2018, Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis, Cell Death Dis., 9, 1056, 10.1038/s41419-018-1074-z

Epstein Shochet, 2020, TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling, Respir Res., 21, 56, 10.1186/s12931-020-1319-0

Chilosi, 2002, Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63, Lab Invest., 82, 1335, 10.1097/01.lab.0000032380.82232.67

Kaarteenaho, 2011, Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders, Pulm Med., 2011, 1, 10.1155/2011/531302

Collard, 2016, Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report, Am J Respir Crit Care Med., 194, 265, 10.1164/rccm.201604-0801CI

Tsui, 2003, Severe acute respiratory syndrome: clinical outcome and prognostic correlates, Emerg Infect Dis., 9, 1064, 10.3201/eid0909.030362

Cheung, 2004, The spectrum of pathological changes in severe acute respiratory syndrome (SARS), Histopathology., 45, 119, 10.1111/j.1365-2559.2004.01926.x

Ketai, 2006, Radiology of Severe Acute Respiratory Syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease, J Thorac Imaging., 21, 276, 10.1097/01.rti.0000213581.14225.f1

Gu, 2007, Pathology and pathogenesis of severe acute respiratory syndrome, Am J Pathol, 170, 1136, 10.2353/ajpath.2007.061088

Tse, 2004, Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS), J Clin Pathol., 57, 260, 10.1136/jcp.2003.013276

Hwang, 2005, Pulmonary pathology of severe acute respiratory syndrome in Toronto, Mod Pathol., 18, 1, 10.1038/modpathol.3800247

Hui, 2005, Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors, Thorax., 60, 401, 10.1136/thx.2004.030205

Ngai, 2010, The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status, Respirology., 15, 543, 10.1111/j.1440-1843.2010.01720.x

Antonio, 2003, Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience, Radiology., 228, 810, 10.1148/radiol.2283030726

de Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol., 14, 523, 10.1038/nrmicro.2016.81

Carfì, 2020, Persistent symptoms in patients after acute COVID-19, JAMA., 324, 603, 10.1001/jama.2020.12603

Goërtz, 2020, Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?, ERJ Open Res., 6, 00542, 10.1183/23120541.00542-2020

Weerahandi, 2020, Post-discharge health status and symptoms in patients with severe COVID-19, medRxiv., 2, 37, 10.1101/2020.08.11.20172742

Shi, 2020, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis, 20, 425, 10.1016/S1473-3099(20)30086-4

Ebner, 2020, Imaging in the aftermath of COVID-19: what to expect, Eur Radiol., 10.1007/s00330-020-07465-6.

Zhao, 2020, Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery, EClinicalMedicine, 25, 100463, 10.1016/j.eclinm.2020.100463

Lerum, 2020, Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19, Eur Respir J., 10.1183/13993003.03448-2020.

Liang, 2020, Three-month follow-up study of survivors of coronavirus disease 2019 after discharge, J Korean Med Sci., 35, e418, 10.3346/jkms.2020.35.e418

Shah, 2021, A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations, Thorax., 76, 402, 10.1136/thoraxjnl-2020-216308

Sonnweber, 2020, Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial, Eur Respir J., 10, 2003481, 10.1183/13993003.03481-2020

van der Sar-van der Brugge, 2020, Pulmonary function and health-related quality of life after COVID-19 pneumonia, Respir Med., 176, 106272, 10.1016/j.rmed.2020.106272

Chuprin, 2013, Cell fusion induced by ERVWE1 or measles virus causes cellular senescence, Genes Dev., 27, 2356, 10.1101/gad.227512.113

Muñoz-Espín, 2014, Cellular senescence: from physiology to pathology, Nat Rev Mol Cell Biol., 15, 482, 10.1038/nrm3823

Childs, 2015, Cellular senescence in aging and age-related disease: from mechanisms to therapy, Nat Med., 21, 1424, 10.1038/nm.4000

Hansel, 2020, Cellular senescence in the lung: the central role of senescent epithelial cells, Int J Mol Sci., 21, 1, 10.3390/ijms21093279

Vitiello, 2020, COVID-19 patients with pulmonary fibrotic tissue: clinical pharmacological rational of antifibrotic therapy, SN Compr Clin Med., 2, 1, 10.1007/s42399-020-00487-7

Jenkins, 2017, An official american thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis, Am J Respir Cell Mol Biol., 56, 667, 10.1165/rcmb.2017-0096ST

Trethewey, 2018, The role of occupational and environmental exposures in the pathogenesis of idiopathic pulmonary fibrosis: a narrative literature review, Medicina, 54, 108, 10.3390/medicina54060108

Padilla-Carlin, 2011, Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole, J Toxicol Environ Health A., 74, 1111, 10.1080/15287394.2011.586940

Shoeb, 2019, Initiation of pulmonary fibrosis after silica inhalation in rats is linked with dysfunctional shelterin complex and DNA damage response, Sci Rep., 9, 471, 10.1038/s41598-018-36712-6

Jin, 2020, Radiation-induced lung fibrosis: preclinical animal models and therapeutic strategies, Cancers., 12, 1, 10.3390/cancers12061561

Nureki, 2018, Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis, J Clin Invest., 128, 4008, 10.1172/JCI99287

Nathan, 2016, Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer, Hum Mol Genet., 25, 1457, 10.1093/hmg/ddw014

Seibold, 2011, A common MUC5B promoter polymorphism and pulmonary fibrosis, N Engl J Med., 364, 1503, 10.1056/NEJMoa1013660

Boutanquoi, 2020, TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling, Eur Respir J, 55, 1901346, 10.1183/13993003.01346-2019

Miyazaki, 1995, Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis, J Clin Invest., 96, 250, 10.1172/JCI118029

Kolb, 2001, Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis, J Clin Invest., 107, 1529, 10.1172/JCI12568

Karkampouna, 2014, Novel ex vivo culture method for the study of dupuytren's disease: effects of TGFβ type 1 receptor modulation by antisense oligonucleotides, Mol Ther Nucleic Acids., 3, e142, 10.1038/mtna.2013.69

Gerckens, 2019, Generation of human 3D Lung Tissue Cultures (3D-LTCs) for disease modeling, J Vis Exp., 10.3791/58437

Alsafadi, 2017, An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices, Am J Physiol Lung Cell Mol Physiol., 312, L896, 10.1152/ajplung.00084.2017

Roach, 2018, A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis, Sci Rep., 8, 342, 10.1038/s41598-017-18555-9

Lehmann, 2018, Differential effects of nintedanib and pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis, Respir Res., 19, 175, 10.1186/s12931-018-0876-y

Wasnick, 2019, Restored alveolar epithelial differentiation and reversed human lung fibrosis upon Notch inhibition, bioRxiv [Preprint]., 10.1101/580498

Montigaud, 2019, Development of an ex vivo respiratory pediatric model of bronchopulmonary dysplasia for aerosol deposition studies, Sci Rep., 9, 5720, 10.1038/s41598-019-42103-2

Sundarakrishnan, 2018, Engineered cell and tissue models of pulmonary fibrosis, Adv Drug Deliv Rev., 129, 78, 10.1016/j.addr.2017.12.013

Liu, 2015, Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis, Am J Physiol Lung Cell Mol Physiol., 308, L344, 10.1152/ajplung.00300.2014

Asano, 2017, Matrix stiffness regulates migration of human lung fibroblasts, Physiol Rep., 5, 1, 10.14814/phy2.13281

Wilkinson, 2017, Development of a three-dimensional bioengineering technology to generate lung tissue for personalized disease modeling, Stem Cells Transl. Med., 6, 622, 10.5966/sctm.2016-0192

Surolia, 2019, Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury, JCI insight., 4, e123253, 10.1172/jci.insight.123253

Strikoudis, 2019, Modeling of fibrotic lung disease using 3d organoids derived from human pluripotent stem cells, Cell Rep., 27, 3709, 10.1016/j.celrep.2019.05.077

Yanagihara, 2020, Current models of pulmonary fibrosis for future drug discovery efforts, Expert Opin Drug Discov., 15, 931, 10.1080/17460441.2020.1755252

Schruf, 2020, Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model, FASEB J., 34, 7825, 10.1096/fj.201902926R

Huh, 2010, Reconstituting organ-level lung functions on a chip, Science., 328, 1662, 10.1126/science.1188302

Low, 2020, Organs-on-chips: into the next decade, Nat Rev Drug Discov., 10.1038/s41573-020-0079-3.

Jain, 2018, Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics, Clin Pharmacol Ther., 103, 332, 10.1002/cpt.742

Felder, 2014, The potential of microfluidic lung epithelial wounding: towards in vivo-like alveolar microinjuries, Integr Biol, 6, 1132, 10.1039/c4ib00149d

Felder, 2012, Microfluidic wound-healing assay to assess the regenerative effect of HGF on wounded alveolar epithelium, Lab Chip., 12, 640, 10.1039/c1lc20879a

Asmani, 2018, Fibrotic microtissue array to predict anti-fibrosis drug efficacy, Nat Commun., 9, 2066, 10.1038/s41467-018-04336-z

Stucki, 2015, A lung-on-a-chip array with an integrated bio-inspired respiration mechanism, Lab Chip., 15, 1302, 10.1039/c4lc01252f

Stucki, 2018, Medium throughput breathing human primary cell alveolus-on-chip model, Sci Rep., 8, 14359, 10.1038/s41598-018-32523-x

Leist, 2020, Cell and animal models of SARS-CoV-2 pathogenesis and immunity, Dis Model Mech., 13, dmm046581, 10.1242/dmm.046581

Bao, 2020, The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, Nature., 583, 830, 10.1038/s41586-020-2312-y

Sun, 2020, A mouse model of SARS-CoV-2 infection and pathogenesis, Cell Host Microbe., 28, 124, 10.1016/j.chom.2020.05.020

Jiang, 2020, Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2, Cell., 182, 50, 10.1016/j.cell.2020.05.027

Winkler, 2020, SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function, Nat Immunol., 21, 1327, 10.1038/s41590-020-0778-2

Dinnon, 2020, A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures, Nature., 586, 560, 10.1038/s41586-020-2708-8

Gu, 2020, Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, Science., 369, 1603, 10.1126/science.abc4730

Shi, 2020, Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2, Science, 368, 1016, 10.1126/science.abb7015

Kim, 2020, Infection and Rapid Transmission of SARS-CoV-2 in Ferrets, Cell Host Microbe., 27, 704, 10.1016/j.chom.2020.03.023

Park, 2020, Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets, MBio., 11, 1, 10.1128/mBio.01114-20

Chan, 2020, Simulation of the clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: implications for disease pathogenesis and transmissibility, Clin Infect Dis., 71, 2428, 10.1093/cid/ciaa325

Chandrashekar, 2020, SARS-CoV-2 infection protects against rechallenge in rhesus macaques, Science., 369, 812, 10.1126/science.abc4776

Lu, 2020, Comparison of nonhuman primates identified the suitable model for COVID-19, Signal Transduct Target Ther., 5, 157, 10.1038/s41392-020-00269-6

Munster, 2020, Respiratory disease in rhesus macaques inoculated with SARS-CoV-2, Nature., 585, 268, 10.1038/s41586-020-2324-7

Rockx, 2020, Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model, Science., 368, 1012, 10.1126/science.abb7314

Yu, 2020, Age-related rhesus macaque models of COVID-19, Anim Model Exp Med., 3, 93, 10.1002/ame2.12108

Ehaideb, 2020, Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review, Crit Care., 24, 594, 10.1186/s13054-020-03304-8

Chu, 2020, Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study, Lancet Microbe., 1, e14, 10.1016/S2666-5247(20)30004-5

Abo, 2020, Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors, bioRxiv [Preprint], 10.1101/2020.06.03.132639

Emeny, 1979, Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production, J Gen Virol., 43, 247, 10.1099/0022-1317-43-1-247

Jia, 2005, ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia, J Virol., 79, 14614, 10.1128/JVI.79.23.14614-14621.2005

Krüger, 2020, Drug inhibition of SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids, Cell Mol Gastroenterol Hepatol., 11, 935, 10.1016/j.jcmgh.2020.11.003

Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell., 181, 905, 10.1016/j.cell.2020.04.004

Stanifer, 2020, Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells, Cell Rep., 32, 107863, 10.1016/j.celrep.2020.107863

Zhao, 2020, Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids, Protein Cell, 11, 771, 10.1007/s13238-020-00718-6

Jonsdottir, 2016, Coronaviruses and the human airway: a universal system for virus-host interaction studies, Virol J, 13, 24, 10.1186/s12985-016-0479-5

V'kovski, 2021, Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium, PLoS Biol., 19, e3001158, 10.1371/journal.pbio.3001158

Si, 2020, Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics, bioRxiv., 2115, 212, 10.1101/2020.04.13.039917

Fuchs, 2003, Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C, Cell Tissue Res., 311, 31, 10.1007/s00441-002-0653-5

Tamò, 2018, Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells, Am J Physiol Lung Cell Mol Physiol., 315, L921, 10.1152/ajplung.00357.2017

Chen, 2017, A three-dimensional model of human lung development and disease from pluripotent stem cells, Nat Cell Biol., 19, 542, 10.1038/ncb3510

Hekman, 2020, Actionable cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2, Mol Cell., 80, 1104, 10.1016/j.molcel.2020.11.028

Duan, 2020, Modeling COVID-19 with human pluripotent stem cell-derived cells reveals synergistic effects of anti-inflammatory macrophages with ACE2 inhibition against SARS-CoV-2, Res Square [Preprint], 10.21203/rs.3.rs-62758/v1

Jacob, 2019, Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells, Nat. Protoc., 14, 3303, 10.1038/s41596-019-0220-0

Chan, 2003, SARS: prognosis, outcome and sequelae, Respirology., 8, S36, 10.1046/j.1440-1843.2003.00522.x

Rogers, 2018, MUC5B promoter polymorphism and development of acute respiratory distress syndrome, Am J Respir Crit Care Med., 198, 1342, 10.1164/rccm.201801-0140LE

Bastard, 2020, Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science., 370, eabd4585, 10.1126/science.abd4585

Zhang, 2020, Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, Science, 370, eabd4570, 10.1126/science.abd4570

Lamers, 2021, An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells, EMBO J., 40, e105912, 10.15252/embj.2020105912

Haji Abdolvahab, 2021, Potential role of interferons in treating COVID-19 patients, Int Immunopharmacol., 90, 107171, 10.1016/j.intimp.2020.107171

Guenat, 2020, Clinically relevant tissue scale responses as new readouts from organs-on-a-chip for precision medicine, Annu Rev Anal Chem, 13, 111, 10.1146/annurev-anchem-061318-114919

Deinhardt-Emmer, 2021, SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction, J Virol., 10.1128/JVI.00110-21.

Wu, 2020, Transcriptional and proteomic insights into the host response in fatal COVID-19 cases, Proc Natl Acad Sci USA., 117, 28336, 10.1073/pnas.2018030117

Lok, 2002, Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice, Eur Respir J, 20, 1228, 10.1183/09031936.02.00272902

Wang, 2017, Respiratory syncytial virus infection accelerates lung fibrosis through the unfolded protein response in a bleomycin-induced pulmonary fibrosis animal model, Mol Med Rep., 16, 310, 10.3892/mmr.2017.6558

Huang, 2019, Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection, PLoS ONE., 14, e0223430, 10.1371/journal.pone.0223430

Miller, 2017, In vitro models to study human lung development, disease and homeostasis, Physiology., 32, 246, 10.1152/physiol.00041.2016

Johansen, 2020, Animal and translational models of SARS-CoV-2 infection and COVID-19, Mucosal Immunol., 13, 877, 10.1038/s41385-020-00340-z

Krimmling, 2017, Comparison of mono- and co-infection by swine influenza A viruses and porcine respiratory coronavirus in porcine precision-cut lung slices, Res Vet Sci., 115, 470, 10.1016/j.rvsc.2017.07.016

Hui, 2020, Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures, Lancet Respir Med., 8, 687, 10.1016/S2213-2600(20)30193-4

Lehmann, 2017, Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo, Eur Respir J, 50, 1602367, 10.1183/13993003.02367-2016

Liu, 2019, Use of precision cut lung slices as a translational model for the study of lung biology, Respir Res., 20, 162, 10.1186/s12931-019-1131-x

Barosova, 2020, Use of epialveolar lung model to predict fibrotic potential of multiwalled carbon nanotubes, ACS Nano., 14, 3941, 10.1021/acsnano.9b06860

Berkers, 2019, Rectal organoids enable personalized treatment of cystic fibrosis, Cell Rep., 26, 1701, 10.1016/j.celrep.2019.01.068

Karkampouna, 2021, Patient-derived xenografts and organoids model therapy response in prostate cancer, Nat. Commun., 12, 1117, 10.1038/s41467-021-21300-6

Sanchez-Esteban, 2001, Mechanical stretch promotes alveolar epithelial type II cell differentiation, J. Appl. Physiol., 91, 589, 10.1152/jappl.2001.91.2.589

Liu, 2016, MAPK-Mediated YAP activation controls mechanical-tension-induced pulmonary alveolar regeneration, Cell Rep., 16, 1810, 10.1016/j.celrep.2016.07.020